Document is current
Any future updates will be listed below
-
Authors
Zhou, Guangfeng https://orcid.org/0000-0003-2728-1917
Rusnac, Domnita-Valeria
Park, Hahnbeom https://orcid.org/0000-0002-7129-1912
Canzani, Daniele
Nguyen, Hai Minh
Stewart, Lance https://orcid.org/0000-0003-4264-5125
Bush, Matthew F. https://orcid.org/0000-0003-3526-4973
Nguyen, Phuong Tran
Wulff, Heike https://orcid.org/0000-0003-4437-5763
Yarov-Yarovoy, Vladimir https://orcid.org/0000-0002-2325-4834
Zheng, Ning https://orcid.org/0000-0002-1039-1581
DiMaio, Frank https://orcid.org/0000-0002-7524-8938
-
Funding
Funding for this research was provided by:
United States Department of Defense | Defense Advanced Research Projects Agency (HR001120S0052, HR001120S0052)
United States Department of Defense | Defense Threat Reduction Agency (GRANT13030960, GRANT13030960)
Howard Hughes Medical Institute
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (P30 GM124169-01, P30 GM124169-01)
National Research Foundation of Korea (2022R1C1C1007817)
National Science Foundation (1807382, 2203513, 1807382, 2203513)
Washington State funding
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
- License Information
-
More Information
Article History
Received: 5 March 2024
Accepted: 23 August 2024
First Online: 5 September 2024
Competing interests
: N.Z. is a scientific cofounder of and has financial interests in SEED Therapeutics. N.Z. serves as a member of the scientific advisory board of Synthex with financial interests and has received research funding from and is a shareholder of Kymera Therapeutics. The findings presented in this manuscript were not discussed with any person in these companies. The authors declare no other competing interests. All other authors declare no competing interests.
